We are live on ! Find out more
NUS icon

Nu Skin

212 hedge funds and large institutions have $870M invested in Nu Skin in 2023 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 99 increasing their positions, 56 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more repeat investments, than reductions

Existing positions increased: 99 | Existing positions reduced: 56

3% less funds holding

Funds holding: 219212 (-7)

4.31% less ownership

Funds ownership: 86.41%82.1% (-4.3%)

16% less call options, than puts

Call options by funds: $1.32M | Put options by funds: $1.56M

18% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 34

39% less capital invested

Capital invested by funds: $1.43B → $870M (-$560M)

Holders
212
Holders Change
-7
Holders Change %
-3.2%
% of All Funds
3.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
28
Increased
99
Reduced
56
Closed
34
Calls
$1.32M
Puts
$1.56M
Net Calls
-$246K
Net Calls Change
-$1.54M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$171M -$2.78M -107,066 -1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$132M +$1.39M +53,638 +0.9%
State Street
3
State Street
Massachusetts
$63.7M -$156M -5,991,569 -67%
Renaissance Technologies
4
Renaissance Technologies
New York
$42.3M -$5M -192,300 -9%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$36.9M -$9.63M -370,461 -18%
Invesco
6
Invesco
Georgia
$35.9M +$21.1M +810,778 +92%
Morgan Stanley
7
Morgan Stanley
New York
$23.4M +$10.1M +388,585 +54%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$23.2M +$1.06M +40,687 +4%
Marshall Wace
9
Marshall Wace
United Kingdom
$21.9M +$9.74M +374,578 +57%
Charles Schwab
10
Charles Schwab
California
$20.9M +$2.96M +113,956 +13%
Citadel Advisors
11
Citadel Advisors
Florida
$20M +$12.4M +477,858 +103%
ACB
12
Aristotle Capital Boston
Massachusetts
$16.5M -$124K -4,775 -0.6%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$16.3M +$1.24M +47,847 +7%
Millennium Management
14
Millennium Management
New York
$15.6M +$15.1M +580,227 +372%
Northern Trust
15
Northern Trust
Illinois
$11.8M +$192K +7,378 +1%
Norges Bank
16
Norges Bank
Norway
$11.7M +$3.3M +126,800 +30%
Victory Capital Management
17
Victory Capital Management
Texas
$9.77M +$4.78M +183,769 +66%
Voloridge Investment Management
18
Voloridge Investment Management
Florida
$9.08M +$10M +385,951 +920%
American Century Companies
19
American Century Companies
Missouri
$8.09M -$2.72M -104,614 -22%
Two Sigma Advisers
20
Two Sigma Advisers
New York
$8M +$9.8M +377,100 New
Goldman Sachs
21
Goldman Sachs
New York
$7.99M +$3.29M +126,713 +51%
Two Sigma Investments
22
Two Sigma Investments
New York
$7.28M +$8.36M +321,700 +1,504%
ProShare Advisors
23
ProShare Advisors
Maryland
$7.22M +$2.64M +101,714 +43%
D.E. Shaw & Co
24
D.E. Shaw & Co
New York
$6.65M +$8.14M +313,303 New
Principal Financial Group
25
Principal Financial Group
Iowa
$5.71M -$370K -14,251 -5%

NUS Hedge Fund Activity: Q3 2023 in Review

212 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Nu Skin (NUS) for Q3 2023, worth a combined $870M — down 39% from $1.43B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of NUS and 28 opened new positions — a net loss of 6 holders — while 56 trimmed existing stakes and 99 added.

The largest buyer was Invesco, adding an estimated $21.1M. The largest seller was State Street, cutting an estimated $156M.

  • 212 institutional investors held Nu Skin (NUS) as of Q3 2023, down from 219 in Q2 2023.
  • Funds reported $870M of Nu Skin stock for Q3 2023, down 39% quarter-over-quarter.
  • 28 funds opened new Nu Skin positions in Q3 2023 and 34 closed out, a net change of -6 holders.
  • The largest Nu Skin buyer in Q3 2023 was Invesco, an estimated $21.1M added.
  • The largest Nu Skin seller in Q3 2023 was State Street, an estimated $156M sold.

Based on aggregated 13F filings for Q3 2023.